Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Mental health effects common among mild and severe cases of COVID-19

Findings on mental health outcomes of COVID-19 infection show frequent symptoms associated with lasting neurological symptoms.

4 Jun 2021

Another symptom of the COVID-19 pandemic: unhealthy eating

In a study of 2,000 people, researchers found that the recent abrupt change in our daily routines caused us to change our eating behaviors.

4 Jun 2021

A lack of oversight for unproven stem cell interventions is a global public health problem

Authors are urging the WHO to establish an Exert Advisory Committee on Regenerative Medicine to provide harmony to the national regulations on the SCI industry.

4 Jun 2021

Methotrexate users fail to achieve adequate immune response to mRNA COVID-19 vaccines

Up to a third of patients taking methotrexate – a common treatment for immune mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis – failed to achieve an adequate immune response to mRNA COVID-19 vaccines in a small study accepted for publication in the journal Annals of the Rheumatic Diseases.

4 Jun 2021

Waters launches new RUO LC-MS test method to advance infectious disease research

Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research.

4 Jun 2021

Novel insights can open doors to combating clotting-related problems in COVID-19

Researchers scour what is known to come up with a hypothesis of why blood clots can be a major problem in COVID-19

4 Jun 2021

Study brings to light the role of a cellular protein in COVID-19 infections

Angiotensin-converting enzyme 2 (ACE2), a protein found on the surface of lung cells, facilitates the entry of the novel coronavirus into host cells.

4 Jun 2021

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

Vaccination efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease (COVID-19) pandemic, are well underway in many countries. Over 2 billion vaccines have been administered to date, and campaigns continue to encourage more people to get vaccinated.

4 Jun 2021

World Health Organization simplifies names of SARS-CoV-2 variants

Now, the World Health Organization (WHO) has assigned simple and easy-to-say labels for key variants of SARS-CoV-2 using letters of the Greek alphabet. The health agency selected these labels after a thorough review of many potential naming systems.

4 Jun 2021

Effect of India's 2021 Assembly Election on COVID-19

In a recent study, Indian researchers from Midnapore City College, and Indian Center for Space Physics, looked at how the assembly elections conducted during the second wave of COVID-19 impacted the transmission of the infection - on the effective contact rate and the effective reproduction number of the SARS-CoV-2 virus. The study is published on the preprint server, medRxiv*.

4 Jun 2021

Study says COVID-19 vaccines passports will likely reduce inclination to accept vaccines

Now, a new study published on medRxiv* preprint server focuses on the quantitative evaluation of the impact of the implementation of vaccine passports for domestic and international travel.

4 Jun 2021

New research focuses on cow's milk as a possible source of COVID-19 control

Physiologically, milk contains biocomponents that are highly protective against infections. In light of this, the AGR-149-Infectious Diseases group at the University of Cordoba's Department of Animal Health is doing research that focuses on cow's milk as a possible source of Covid-19 control. The results have been published, partially, in the journal Frontiers in Immunology.

4 Jun 2021

UK study reports on attitudes to COVID-19 symptoms and testing

Researchers from King’s College London and Public Health England studied how people engage with the NHSTT, in particular, how people recognize symptoms and get tested. They reported their results in a paper published on the medRxiv* preprint server.

4 Jun 2021

Study: Nasal therapy is more effective than commonly used IgG antibodies at neutralizing COVID-19 virus

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc.

4 Jun 2021

People who received Pfizer-Biontech vaccine have lower antibody levels targeting the delta variant

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.

4 Jun 2021

Plant-based oil blend shows virucidal activity against SARS-CoV-2 and influenza viruses in vitro

A new preprint research paper posted to the bioRxiv* server offers a potential candidate for disinfecting the respiratory tract and mouth during and after exposure to the virus, in the form of proprietary herbal oil named Viruxal.

3 Jun 2021

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

A preprint paper uploaded to the bioRxiv* server shows how combining drugs targeting different entry factors of the host cell may prevent infection by the virus.

3 Jun 2021

Mast cell activation may underlie inflammation in severe COVID-19

A new preprint research paper posted to the medRxiv* server points to mast cells as major culprits in the etiology of severe and critical COVID-19. This could suggest suitable therapeutic and preventive interventions to reduce the morbidity and mortality of this viral illness.

3 Jun 2021

New method gives an accurate real-time estimate of epidemic trajectories

A new method to monitor epidemics like COVID-19 gives an accurate real-time estimate of the growth rate of an epidemic by carefully evaluating the relationship between the amount of viruses in infected people's bodies, called the viral load, and how fast the number of cases is increasing or decreasing.

3 Jun 2021

NIH study identifies promising oral antiviral treatment for COVID-19

The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health.

3 Jun 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Mental health effects common among mild and severe cases of COVID-19

Another symptom of the COVID-19 pandemic: unhealthy eating

A lack of oversight for unproven stem cell interventions is a global public health problem

Methotrexate users fail to achieve adequate immune response to mRNA COVID-19 vaccines

Waters launches new RUO LC-MS test method to advance infectious disease research

Novel insights can open doors to combating clotting-related problems in COVID-19

Study brings to light the role of a cellular protein in COVID-19 infections

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

World Health Organization simplifies names of SARS-CoV-2 variants

Effect of India's 2021 Assembly Election on COVID-19

Study says COVID-19 vaccines passports will likely reduce inclination to accept vaccines

New research focuses on cow's milk as a possible source of COVID-19 control

UK study reports on attitudes to COVID-19 symptoms and testing

Study: Nasal therapy is more effective than commonly used IgG antibodies at neutralizing COVID-19 virus

People who received Pfizer-Biontech vaccine have lower antibody levels targeting the delta variant

Plant-based oil blend shows virucidal activity against SARS-CoV-2 and influenza viruses in vitro

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

Mast cell activation may underlie inflammation in severe COVID-19

New method gives an accurate real-time estimate of epidemic trajectories

NIH study identifies promising oral antiviral treatment for COVID-19

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in